Delayed presentation of postinfectious encephalitis associated with SARS-CoV-2 infection: a case report.
Champika GunawardhanaGeetha NanayakkaraDhanusha GamageIndika WithanageManjeewa BandaraChandima SiriwimalaNipun SenaratneThashi ChangPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2021)
Neurological manifestations of SARS-CoV-2 are increasingly being recognised and can arise as a result of direct viral invasion, para-infectious or postinfectious immune mechanisms. We report a delayed presentation of COVID-19 postinfectious immune-mediated encephalitis and status epilepticus occurring in a 47-year-old woman 4 weeks after SARS-CoV-2 pulmonary disease. SARS-CoV-2-specific IgG and IgM antibodies were detected in her cerebrospinal fluid with features of encephalitis evident in both magnetic resonance imaging of the brain and electroencephalogram. She made a complete recovery following treatment with high-dose intravenous corticosteroids and intravenous immunoglobulins. Diagnosis of COVID-19 postinfectious encephalitis may prove challenging in patients presenting many weeks following the initial infection. A high index of clinical suspicion and testing intrathecal SARS-CoV-2-specific antibodies are key to its diagnosis. Early immunotherapy is likely to result in a good outcome.
Keyphrases
- sars cov
- high dose
- respiratory syndrome coronavirus
- magnetic resonance imaging
- cerebrospinal fluid
- end stage renal disease
- case report
- ejection fraction
- low dose
- newly diagnosed
- stem cell transplantation
- chronic kidney disease
- computed tomography
- pulmonary hypertension
- prognostic factors
- white matter
- multiple sclerosis
- magnetic resonance
- patient reported outcomes
- brain injury
- cerebral ischemia
- replacement therapy
- diffusion weighted imaging